Hepatitis C
Showing NaN - NaN of 61
Hepatitis C, Hepatocellular Carcinoma Trial in New Zealand, Spain, United States (Sofosbuvir, Ribavirin)
Completed
- Hepatitis C
- Hepatocellular Carcinoma
-
Los Angeles, California
- +14 more
Jun 16, 2016
Plasma and Serum Samples From Individuals Initiating Sofosbuvir
Completed
- Hepatitis C
-
North Little Rock, Arkansas
- +33 more
Feb 2, 2016
Hepatitis C, Liver Transplantation Trial in Worldwide (cyclosporin (Neoral), tacrolimus (Prograf))
Completed
- Hepatitis C
- Liver Transplantation
- cyclosporin (Neoral)
- tacrolimus (Prograf)
-
Phoenix, Arizona
- +44 more
May 5, 2015
Hepatitis C, Human Immunodeficiency Virus Trial in Puerto Rico, United States (SOF, RBV)
Completed
- Hepatitis C
- Human Immunodeficiency Virus
-
Birmingham, Alabama
- +26 more
Nov 14, 2014
Hepatitis C Trial in Belgium, United States (ACH-0141625 (Sovaprevir), Placebo, Pegylated Interferon alpha-2a)
Completed
- Hepatitis C
- ACH-0141625 (Sovaprevir)
- +3 more
-
Los Angeles, California
- +17 more
Sep 8, 2014
Maternal Hepatitis C Infection and Influenza Vaccination in
Terminated
- Hepatitis C
-
San Francisco, CaliforniaSan Francisco General Hospital, University of California, San Fr
Aug 21, 2014
Hepatitis C Trial in Worldwide (biological, drug, other)
Completed
- Hepatitis C
- Pegylated Interferon Alfa 2a
- +3 more
-
Birmingham, Alabama
- +115 more
Jul 16, 2014
HIV, Hepatitis C Trial in San Francisco (Alcohol, Alcohol )
Completed
- HIV Infections
- Hepatitis C
- Alcohol
- Alcohol placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 2, 2014
Hepatitis C, HIV Trial in Worldwide (telaprevir or matching , peginterferon alfa-2a, ribavirin (fixed dose))
Completed
- Hepatitis C
- HIV Infections
- telaprevir or matching placebo
- +3 more
-
Beverly Hills, California
- +15 more
Aug 2, 2013